Mizuta K - Search Results

1

Impairment of endothelial-mesenchymal transformation during atrioventricular cushion formation in Tmem100 null embryos.

Mizuta K, Sakabe M, Hashimoto A, Ioka T, Sakai C, Okumura K, Hattammaru M, Fujita M, Araki M, Somekawa S, Saito Y, Nakagawa O. Mizuta K, et al. Dev Dyn. 2015 Jan;244(1):31-42. doi: 10.1002/dvdy.24216. Epub 2014 Nov 7. Dev Dyn. 2015. PMID: 25318679 Free article.

2

An important role of endothelial hairy-related transcription factors in mouse vascular development.

Morioka T, Sakabe M, Ioka T, Iguchi T, Mizuta K, Hattammaru M, Sakai C, Itoh M, Sato GE, Hashimoto A, Fujita M, Okumura K, Araki M, Xin M, Pedersen RA, Utset MF, Kimura H, Nakagawa O. Morioka T, et al. Among authors: mizuta k. Genesis. 2014 Nov;52(11):897-906. doi: 10.1002/dvg.22825. Epub 2014 Oct 10. Genesis. 2014. PMID: 25264302

3

Expression pattern of Runt-related transcription factor (RUNX) family members and the role of RUNX1 during kidney development.

Yano-Sakamoto K, Kitai Y, Toriu N, Yamamoto S, Mizuta K, Saitou M, Tsukiyama T, Taniuchi I, Osato M, Yanagita M. Yano-Sakamoto K, et al. Among authors: mizuta k. Biochem Biophys Res Commun. 2024 Aug 30;722:150155. doi: 10.1016/j.bbrc.2024.150155. Epub 2024 May 22. Biochem Biophys Res Commun. 2024. PMID: 38795454 Free article.

4

Nucleome programming is required for the foundation of totipotency in mammalian germline development.

Nagano M, Hu B, Yokobayashi S, Yamamura A, Umemura F, Coradin M, Ohta H, Yabuta Y, Ishikura Y, Okamoto I, Ikeda H, Kawahira N, Nosaka Y, Shimizu S, Kojima Y, Mizuta K, Kasahara T, Imoto Y, Meehan K, Stocsits R, Wutz G, Hiraoka Y, Murakawa Y, Yamamoto T, Tachibana K, Peters JM, Mirny LA, Garcia BA, Majewski J, Saitou M. Nagano M, et al. Among authors: mizuta k. EMBO J. 2022 Jul 4;41(13):e110600. doi: 10.15252/embj.2022110600. Epub 2022 Jun 15. EMBO J. 2022. PMID: 35703121 Free PMC article.

5

Ex vivo reconstitution of fetal oocyte development in humans and cynomolgus monkeys.

Mizuta K, Katou Y, Nakakita B, Kishine A, Nosaka Y, Saito S, Iwatani C, Tsuchiya H, Kawamoto I, Nakaya M, Tsukiyama T, Nagano M, Kojima Y, Nakamura T, Yabuta Y, Horie A, Mandai M, Ohta H, Saitou M. Mizuta K, et al. EMBO J. 2022 Sep 15;41(18):e110815. doi: 10.15252/embj.2022110815. Epub 2022 Aug 1. EMBO J. 2022. PMID: 35912849 Free PMC article.

6

Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models.

Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: mizuta k. In Vivo. 2025 Jan-Feb;39(1):120-126. doi: 10.21873/invivo.13809. In Vivo. 2025. PMID: 39740911

7

The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo.

Morinaga S, Zhao M, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: mizuta k. In Vivo. 2025 Jan-Feb;39(1):102-109. doi: 10.21873/invivo.13807. In Vivo. 2025. PMID: 39740880

8

Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase Concentrations.

Kang BM, Han Q, Mizuta K, Morinaga S, Bouvet M, Hoffman RM. Kang BM, et al. Among authors: mizuta k. Anticancer Res. 2025 Jan;45(1):105-111. doi: 10.21873/anticanres.17397. Anticancer Res. 2025. PMID: 39740830

9

Relationship Between ¹⁸F-FDG-PET/CT-derived Tumor Glucose Metabolic Activity, Nutritional Risk, and Survival in Patients With Soft-tissue Sarcoma.

Oshiro H, Mizuta K, Miyashi Y, Yoshikawa Y, Tome Y, Nishida K. Oshiro H, et al. Among authors: mizuta k. Anticancer Res. 2025 Jan;45(1):351-357. doi: 10.21873/anticanres.17423. Anticancer Res. 2025. PMID: 39740823

10

Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells.

Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: mizuta k. Anticancer Res. 2025 Jan;45(1):97-103. doi: 10.21873/anticanres.17396. Anticancer Res. 2025. PMID: 39740811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

762 results

Search Page

Filters